Work

Safety and efficacy of necitumumab continuation therapy: Subgroup analysis of phase 3 SQUIRE study.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e19024

Authors: Tudor E. Ciuleanu, Mark A. Socinski, Coleman K. Obasaju, Alexander Luft, Aleksandra Szczesna, Wojciech Szafranski, Rodryg Ramlau, Beatrix Bálint, Andrzej Kazarnowicz, Olivier Molinier, Henrik Depenbrock, Shivani Nanda, Luis Paz-Ares, Nick Thatcher

Institutions: Institute of Oncology Prof. Dr. Ion Chiricuta, University of Pittsburgh, Eli Lilly (United States), Poznan University of Medical Sciences, Eli Lilly (Germany), Hospital Universitario 12 De Octubre, The Christie Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603309552

Cites:

Cited by: 1

Related to: 10